MOBILE Health Intervention in IntraCerebral Hemorrhage Survivors

Recruiting N/A Interventional Study
Intracerebral Hemorrhage Hypertension
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
140 (estimated)
Sponsor
The University of Hong Kong · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This randomized controlled trial investigates the efficacy and safety of mobile health intervention in managing hypertension after Intracerebral Hemorrhage (ICH).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Primary ICH Diagnosis * Age ≥ 18 years * Discharge Modified Rankin Scale of ≤4 Exclusion Criteria: * Expected life expectancy of \<1 year * Patient or caregiver does not have access to WeRISE App. * Patient or caregiver does not know how to use WeRISE App . * Inability to pe…
Contacts

Kay Cheong Teo, MBBS

(852)22553749

kcteo@hku.hk

CONTACT